Answer
Talzenna, combined with enzalutamide, is indicated for adults with metastatic castration-resistant prostate cancer in whom chemotherapy is not clinically indicated.
Sources for this answer
- Talzenna 1mg Hard CapsulesPfizer Limited · emc · SmPC §4.1 Therapeutic Indications · Version 10Document updated
Sources checked